728
Participants
Start Date
February 28, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Dapagliflozin
Oral Dose 5 or 10 mg
Research Site, Nagoya
Research Site, Owariasahi
Research Site, Toyohashi
Research Site, Hirosaki
Research Site, Niihama
Research Site, Fukuoka
Research Site, Itoshima
Research Site, Yukuhashi
Research Site, Annaka
Research Site, Ōta
Research Site, Aki-gun
Research Site, Hiroshima
Research Site, Sapporo
Research Site, Sanuki
Research Site, Takamatsu
Research Site, Kamakura
Research Site, Kawasaki
Research Site, Yokohama
Research Site, Zushi
Research Site, Kochi
Research Site, Sendai
Research Site, Matsumoto
Research Site, Osaka
Research Site, Suita
Research Site, Ōtsu
Research Site, Atami
Research Site, Shizuoka
Research Site, Komatsushimachō
Research Site, Chiyoda City
Research Site, Chūō
Research Site, Mitaka
Research Site, Ōta-ku
Research Site, Shibuya City
Research Site, Shinjuku
Research Site, Taitō City
Research Site, Takaoka
Research Site, Toyama
Research Site, Ube
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Bristol-Myers Squibb
INDUSTRY